Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon
- PMID: 6193516
- PMCID: PMC384263
- DOI: 10.1073/pnas.80.17.5397
Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon
Abstract
Human cell lines of hematopoietic origin were tested for production of tumor necrosis factor (TNF). B-cell lines transformed by Epstein-Barr virus release a factor (referred to as hTNF) that is cytotoxic for mouse L cells sensitive to mouse TNF but not for L cells resistant to mouse TNF. Exposure to 4 beta-phorbol 12 beta-myristate 13 alpha-acetate augmented production of hTNF. hTNF activity was not found in supernatants of cell lines of T-cell, monocytic, or promyelocytic origin. Partially purified hTNF has a molecular weight of approximately 70,000, has no interferon activity, is acid labile, is destroyed by heating at 70 degrees C for 1 hr, induces cross-resistance to mouse TNF in vitro, and causes hemorrhagic necrosis of Meth A mouse sarcoma in the standard in vivo mouse TNF assay. Tests with a panel of 23 human cancer cell lines showed that hTNF is cytotoxic for 7 cell lines, cytostatic for 5, and has no effect on 11. Comparative studies with human alpha, beta, and gamma interferons indicated that sensitivity to hTNF and interferon can be distinguished. Combined treatment with hTNF and alpha or gamma interferon resulted in a synergistic cytotoxic effect.
Similar articles
-
Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.J Exp Med. 1985 Nov 1;162(5):1512-30. doi: 10.1084/jem.162.5.1512. J Exp Med. 1985. PMID: 3932579 Free PMC article.
-
Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor.J Exp Med. 1986 Oct 1;164(4):1350-5. doi: 10.1084/jem.164.4.1350. J Exp Med. 1986. PMID: 3020152 Free PMC article.
-
Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.J Immunol. 1986 Oct 15;137(8):2592-8. J Immunol. 1986. PMID: 3760569
-
Tumor necrosis factors.Semin Surg Oncol. 1989;5(6):402-13. doi: 10.1002/ssu.2980050606. Semin Surg Oncol. 1989. PMID: 2688030 Review.
-
Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition.Blut. 1987 Jul;55(1):1-10. doi: 10.1007/BF00319635. Blut. 1987. PMID: 3038218 Review. No abstract available.
Cited by
-
The Functional Response of B Cells to Antigenic Stimulation: A Preliminary Report of Latent Tuberculosis.PLoS One. 2016 Apr 6;11(4):e0152710. doi: 10.1371/journal.pone.0152710. eCollection 2016. PLoS One. 2016. PMID: 27050308 Free PMC article.
-
An overview of the history and biologic properties of tumor necrosis factors.Springer Semin Immunopathol. 1986;9(1):33-7. doi: 10.1007/BF00201903. Springer Semin Immunopathol. 1986. PMID: 3523803 Review. No abstract available.
-
Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression.Nucleic Acids Res. 1985 Jun 25;13(12):4417-29. doi: 10.1093/nar/13.12.4417. Nucleic Acids Res. 1985. PMID: 2989794 Free PMC article.
-
Promotion of murine antitumor activity by prothymosin alpha treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor alpha.Cancer Immunol Immunother. 1992;35(2):145-50. doi: 10.1007/BF01741862. Cancer Immunol Immunother. 1992. PMID: 1596938 Free PMC article.
-
Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model.J Neurooncol. 1991 Apr;10(2):95-109. doi: 10.1007/BF00146870. J Neurooncol. 1991. PMID: 1716671
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials